AVIKURE CV 625

Avikure CV 625: High‑Strength Combo Tablet of Amoxicillin + Potassium Clavulanate

Introduction to Avikure CV 625

Avikure CV 625 is an advanced combination antibiotic tablet containing Amoxicillin 500 mg plus Clavulanic Acid 125 mg, offering superior antibacterial activity against beta‑lactamase-producing organisms. Avikure CV 625 delivers broad‑spectrum infection control, making it a top choice among healthcare professionals for a wide range of respiratory, urinary, ENT, skin, and intra‑abdominal infections.

---

Key Features of Avikure CV 625

Dual-Action Antibiotic Power

Avikure CV 625 combines Amoxicillin 500 mg, a potent bactericidal agent, with Clavulanic Acid 125 mg, a beta‑lactamase inhibitor. This powerful synergy enhances efficacy against resistant bacterial strains.

Rapid Absorption & High Bioavailability

Formulated for fast gastrointestinal absorption, Avikure CV 625 achieves therapeutic plasma levels quickly, delivering prompt symptom relief.

Trusted Clinical Potency

Avikure CV 625 is widely accepted by doctors for its effectiveness in cases where single‑agent antibiotics have failed, especially in resistant bacterial infections.

---

Clinical Indications for Avikure CV 625

1. Acute Respiratory Infections

Effective in treating:

• Acute sinusitis, otitis media, and bronchitis

• Community‑acquired pneumonia, including resistant strains

2. ENT Infections

Avikure CV 625 is preferred for:

• Tonsillitis, pharyngitis, and laryngitis

• Recurrent or chronic ENT infections

3. Urinary Tract Infections (UTIs)

Highly effective against:

• Uncomplicated and complicated UTIs, including pyelonephritis

• Infections involving ESBL‑producing E. coli or Klebsiella

4. Skin & Soft Tissue Infections

Covers:

• Cellulitis, wound infections, and abscesses

• Infections caused by resistant Staph and PEK organisms

5. Intra-Abdominal Infections

Used for:

• Mixed aerobic‑anaerobic infections

• Post-surgical or perforation‑related abdominal infections

---

Mechanism of Action

How Avikure CV 625 Works

Avikure CV 625 works by combining:

• Amoxicillin: disrupts bacterial cell wall synthesis by binding penicillin‑binding proteins

• Clavulanic Acid: inhibits beta‑lactamase enzymes, preventing antibiotic degradation

This dual mechanism ensures broad antibacterial coverage even against resistant pathogens.

---

Dosage & Administration Guidelines

For Adults

• One tablet (625 mg) twice daily, preferably after meals

• Course duration: 5–10 days, depending on infection severity

• Stay hydrated and complete the full course even if symptoms improve early

Special Populations

• Dose reduction recommended in renal impairment

• Not recommended in pregnancy or lactation unless advised by a physician

• Not for children; use pediatric formulations like Avikure CV Kid

---

Benefits of Avikure CV 625

1. Broad-Spectrum Efficacy

Avikure CV 625 is effective against:

• Gram‑positive and gram‑negative bacteria

• Beta‑lactamase‑producing strains of Staphylococcus, E. coli, Klebsiella, and others

2. High Clinical Success Rate

Doctors report rapid clinical improvement in infections where monotherapy failed, thanks to Avikure CV 625’s enhanced coverage.

3. Well-Tolerated with Food

Taking Avikure CV 625 with meals reduces gastrointestinal discomfort and improves tablet absorption.

4. Affordable & Accessible

Offers robust antibiotic coverage at a cost-effective price point—accessible for providers and patients alike.

---

Safety & Side Effects

Common Side Effects

• Diarrhea or loose motions

• Nausea or vomiting

• Abdominal pain or discomfort

• Mild headache

Less Common but Important

• Hypersensitivity reactions (rash, urticaria, bronchospasm)

• Liver enzyme elevation

• Potential candidiasis with prolonged use

Seek medical advice if symptoms persist or worsen.

---

Precautions & Warnings

Before Taking Avikure CV 625

• Disclose any allergy to penicillin or cephalosporins

• Inform healthcare provider of kidney or liver issues

• Avoid use in pregnancy or lactation unless strictly guided by a physician

Drug Interactions

• Concurrent use with allopurinol, probenecid, or oral contraceptives may alter drug response

• May interfere with urine glucose tests—notify lab staff

---

Storage & Handling

• Store below 25 °C, away from moisture and sunlight

• Keep in original blister packaging until use

• Keep out of reach of children

• Discard unused medication after expiry

Frequently Asked Questions (FAQs)

Is Avikure CV 625 effective against resistant bacteria?

Yes, the Clavulanic Acid component allows Avikure CV 625 to overcome beta‑lactamase‑mediated resistance.

Can Avikure CV 625 be taken with probiotics?

Yes. Probiotics may help reduce antibiotic-associated diarrhea during treatment with Avikure CV 625.

Is dose adjustment required for kidney-impaired patients?

Yes, those with significant renal impairment should have their dose adjusted. Consult a physician for proper dosing.

Can Avikure CV 625 be used for ear infections in children?

No. Pediatric formulations like Avikure CV Kid are recommended instead.

Why Avikure CV 625 Stands Out

Efficacy + Resistance Coverage

With dual-action against bacteria and enzyme inhibitors, Avikure CV 625 ensures higher therapeutic success where single agents fail.

Physician-Recommended Treatment

Clinicians trust Avikure CV 625 for severe or resistant infections, especially in adult patients who require reliable outcomes.

AI-Assured Manufacturing Quality

Produced with AI-integrated pharmaceutical processes, Avikure CV 625 guarantees:

• Tablet uniformity and potency

• Batch consistency

• Compliance with WHO-GMP and ISO standards

---

Final Verdict: Choose Avikure CV 625 for Confident Antibacterial Therapy

Avikure CV 625 is your go-to adult combination antibiotic tablet, offering powerful dual action, proven effectiveness against resistant bacteria, and fast clinical relief. Ideal for respiratory, ENT, urinary, skin, and abdominal infections, Avikure CV 625 combines reliability, affordability, and trust—making it the ultimate choice for both patients and healthcare professionals.

Choose Avikure CV 625 today for optimized infection management and enhanced clinical outcomes.